Synergistic Cytotoxicity of Recombinant Human TNF and Various Anti-Cancer Drugs

Authors:
  • YNYoshiro Niitsu
    Yoshiro Niitsu
  • NYNaofumi Yamauchi
    Naofumi Yamauchi
  • YOYoshiki Ohtsuka
    Yoshiki Ohtsuka
  • HSHisao Sone
    Hisao Sone
  • HNHiroshi Neda
    Hiroshi Neda
  • MMMasahiro Maeda
    Masahiro Maeda
  • IUIchiro Urushizaki
    Ichiro Urushizaki

Abstract
A synergistic increase in the cytotoxic effects of recombinant human tumor necrosis factor (rH-TNF) and anti-cancer drugs was demonstrated in vitro. The cytotocicity of rH-TNF against L-M cells in combination with Mitomycin C (MMC), Adriamycin (ADM), Cytosine arabinoside (Ara- C), Actinomycin D (ACD), Daunomycin (DM), Cisplatin (CDDP), Vincristin (VCR), and 5-Flurouracil (5FU), based on the concentration necessary for 50% inhibition of cell growth (IC50), was 4 to 347 times as high as that of rH-TNF alone. The results suggest that combination therapy including rH-TNF and anti-cancer drugs may be of value in the treatment of malignancy in human patients.

This publication has 4 references indexed in Scilit: